Phase 3 N=216 Girls OnGuard: HPV Vaccination Uptake Among African American Adolescent Females
Vaccination
Primary: GARDASIL Vaccination Uptake and Compliance With Second and Third Doses — 12; 12; 8; 3 participants — p=>.05
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 3 N=34 Trial of Citicoline Therapy in Patients With Mania or Hypomania and Cocaine Abuse/Dependence
Mania · Hypomania · Cocaine Abuse
Primary: Cocaine Use Determined by Urine Analysis — 62.50; 50.00 percentage of participants no cocaine — p=.4637
Phase 3 N=234 A Long Term Extension Study Evaluating Safety Of Sildenafil Citrate When Used To Treat Pulmonary Arterial Hypertension (PAH) In Children
Pulmonary Arterial Hypertension
Primary: Number of Participants Reporting at Least One Adverse Event — 41; 55; 73; 13 Participants
Phase 3 N=345 Efficacy and Safety of an Ophthalmic Solution in Patients With Allergic Conjunctivitis
Allergic Conjunctivitis
Primary: Mean Ocular Itching at Onset of Action — 0.38; 0.47; 0.59; 1.91 units on a scale
Phase 3 N=20 Effects of Gastric Bypass on Blood Levels of Duloxetine
Bariatric Surgery
Primary: Cmax — 51.04; 61.41 ng/ml
Phase 3 N=849 Efficacy Study of Antiseptic Preoperative Scrubs in Prevention of Postoperative Infections
Postoperative Wound Infection
Primary: The Primary Objective of This Trial is to Compare the Impact of Disinfecting the Skin With Chloraprep vs. Betadine on the Rates of Infection of Clean-contaminated…
Phase 3 N=287 Phase III Confirmatory Study of DE-089 Ophthalmic Solution in Patients With Dry Eye
Dry Eye
Primary: Mean Change in Fluorescein Staining Score From Baseline — -2.12; -2.08 points
Phase 3 N=189 Vitamin E in Preventing Peripheral Neuropathy Caused by Chemotherapy in Patients Receiving Chemotherapy for Cancer
Neurotoxicity · Unspecified Adult Solid Tumor, Protocol Specific
Primary: Percentage of Patients With Chemotherapy-induced Sensory Peripheral Neuropathy ≥ Grade 2 — 34; 29 percentage of participants — p=0.43
Phase 3 N=398 Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
Asthma
Primary: FEV1 peak0-3 Change From Baseline — 0.373; 0.507; 0.547 Litres — p=0.0085
Phase 3 N=131 Long-term Safety Study for GSK573719 in Japanese
Pulmonary Disease, Chronic Obstructive
Primary: Number of Participants With Any Adverse Event (AE) or Any Serious Adverse Event (SAE) Throughout the Treatment Period — 105; 17 Participants
Phase 3 N=1,549 Efficacy and Safety of Empagliflozin (BI 10773) With Metformin in Patients With Type 2 Diabetes
Diabetes Mellitus, Type 2
Primary: The Change From Baseline in Glycosylated Haemoglobin (HbA1c) After 104 Weeks of Treatment. — -0.66; -0.55 percentage of HbA1c — p=<0.0001
Phase 3 N=123 A Study of Avastin (Bevacizumab) and Xeloda (Capecitabine) as Maintenance Treatment in Patients With Metastatic Colorectal Cancer
Colorectal Cancer
Primary: Progression-free Survival — 9.0; 12.6 Months
Phase 3 N=460 Efficacy, Safety and Tolerability of NVA237 in Patients With Chronic Obstructive Pulmonary Disease
Chronic Obstructive Pulmonary Disease (COPD)
Primary: Trough Forced Expiratory Volume in One Second (FEV1) — 1.204; 1.063 Liters
Phase 3 N=120 Effects of Desoximetasone Spray 0.25% on Moderate to Severe Plaque Psoriasis
Psoriasis
Primary: Clinical Success — 18; 3 participants — p=0.0003
Phase 3 N=413 Optimizing Treatment for Treatment-Experienced, HIV-Infected People
HIV Infections
Primary: Percent of Participants With Regimen Failure, Defined as a Confirmed Virologic Failure or Discontinuation of Randomized NRTI Component of Study Treatment — 26.0; 29.8…